Tiptoeing into the broader accountability movement, some of the largest medical-device manufacturers are negotiating experimental deals with hospitals to take on performance-based financial risk for their implants.
Chronic illnesses and diseases pose some of the greatest challenges for managing population health. Obesity, for example, affects more than one-third of American adults. Yet its causes are largely due to lifestyle factors that cannot be adequately addressed in just a couple of doctor's visits.
As one of the most data-driven departments within a healthcare organization, the supply chain is playing an increasingly important role in reducing costs and improving patient outcomes.
The Ebola scare has subsided in the United States, at least temporarily, but an Alabama manufacturer is still trying to catch up with a glut of orders for gear to protect against the disease.
A government watchdog wants to know if hospitals accurately report revenue they receive from group purchasing organizations, a question that may have broader implications for the federal safe harbor that allows GPOs to earn and distribute such administrative fees.
As the number of medical-device recalls has rapidly increased, so has the complexity of the recalls. That is raising questions about safety and risks for hospitals that mostly still track and locate faulty products manually.
For many systems across the country, the expense side of the balance sheet is growing almost as fast as the revenue side, prompting providers to look for new ways to cut costs.
Some low-cost generic drugs that have helped restrain healthcare costs for decades are seeing unexpected price spikes of up to 8,000%, prompting a backlash from patients, pharmacists and now lawmakers.
About one-fifth of the hospitals, health systems and purchasing groups that own the Premier healthcare alliance made nearly $120 million by selling shares in a secondary offering underway this month.
The average price of computed tomography systems went up 15% in the past month as more hospitals purchased high-end scanners, including two new premium models that have been on the market for less than a year, according to the Modern Healthcare/ECRI Institute Technology Price Index.
The important work of group purchasing organizations has been the subject of several recent studies, including a new survey sponsored by the American Hospital Association and conducted by Lawton Robert Burns at the Wharton School. While I am heartened that Burns found that GPOs produce savings and...
Lower taxes for medical device makers. Lighter regulations for coal. If the new Republican-led Congress manages to push through these policy changes it could lift stocks in the health and energy industries, market strategists say.